(Q71804762)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930429%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

The lipid-lowering effects of atorvastatin, a new HMG-CoA reductase inhibitor: results of a randomized, double-masked study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930429%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

T M Heinonen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930429%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

E Stein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930429%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

S R Weiss

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930429%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

J M McKenney

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930429%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

M Davidson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930429%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

L Shurzinske

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930429%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

D M Black

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930429%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 September 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930429%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

published in

Clinical Therapeutics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930429%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930429%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

853-863

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930429%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930429%20AND%20SRC:MED&resulttype=core&format=json

Cholesterol and mortality. 30 years of follow-up from the Framingham study

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980045-2

7 January 2021

An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980045-2

7 January 2021

Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980045-2

7 January 2021

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980045-2

7 January 2021

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980045-2

7 January 2021

Plasma triglyceride and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980045-2

7 January 2021

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980045-2

7 January 2021

Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980045-2

7 January 2021

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980045-2

7 January 2021

Atorvastatin, a New HMG-CoA Reductase Inhibitor as Monotherapy and Combined With Colestipol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980045-2

7 January 2021

10.1016/S0149-2918(96)80045-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8930429%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference